KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Bio-Rad Laboratories (BIO) Leases (2019 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Leases for 7 consecutive years, with $170.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Leases rose 5.92% to $170.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $170.0 million, a 5.92% increase, with the full-year FY2025 number at $170.0 million, up 5.92% from a year prior.
  • Leases was $170.0 million for Q4 2025 at Bio-Rad Laboratories, down from $180.3 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $204.8 million in Q4 2021 to a low of $153.2 million in Q1 2025.
  • A 5-year average of $183.7 million and a median of $183.3 million in 2022 define the central range for Leases.
  • Peak YoY movement for Leases: rose 16.56% in 2023, then dropped 18.91% in 2025.
  • Bio-Rad Laboratories' Leases stood at $204.8 million in 2021, then dropped by 11.62% to $181.0 million in 2022, then rose by 7.57% to $194.7 million in 2023, then fell by 17.57% to $160.5 million in 2024, then increased by 5.92% to $170.0 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Leases are $170.0 million (Q4 2025), $180.3 million (Q3 2025), and $190.4 million (Q2 2025).